Implications thérapeutiques du titrage sérique des anticorps anti-PLA2R dans la glomérulonéphrite extra-membraneuse idiopathique : à propos d’un cas clinique
Résumé
Texte intégral :
PDFRéférences
REFERENCES 1. Couser WG. Primary Membranous Nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983‑97. 2. Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int. 2017;91(3):566‑74. 3. De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC. A Proposal for a SerologyBased Approach to Membranous Nephropathy. J Am Soc Nephrol. 2017;28(2):421‑30. 4. Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. Mtype phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11‑21. 5. Zajjari Y, Aatif T, Bahadi A, Hassani K, El Kabbaj D, Benyahia M. Kidney biopsy in the Military Hospital of Morocco: Complications and histopathological findings. Saudi J Kidney Dis Transplant. 2015;26(5):1044‑9. 6. Okpechi I, Swanepoel C, Duffield M, Mahala B, Wearne N, Alagbe S, et al. Patterns of renal disease in Cape Town South Africa: a 10-year review of a singlecentre renal biopsy database. Nephrol Dial Transplant. 2011;26(6):1853‑61. 7. Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, et al. Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy. J Am Soc Nephrol. 2012;23(10):1735‑43. 8. Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, et al. An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26(8):2526‑32. 9. Qin W, Beck LH, Zeng C, Chen Z, Li S, Zuo K, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137‑43. 10. Du Y, Li J, He F, Lv Y, Liu W, Wu P, et al. The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PloS One. 2014;9(8): e104936.11. Stehlé T, Audard V, Ronco P, Debiec H. Phospholipase A2 receptor and sarcoidosisassociated membranous nephropathy. Nephrol Dial Transplant. 2015;30(6):1047‑50. 12. Noël LH, Aucouturier P, Monteiro RC, Preud’Homme JL, Lesavre P. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and antiglomerular basement membrane nephritis. Clin Immunol Immunopathol. 1988;46(2):186‑94. 13. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19(3):574‑9. 14. Qu Z, Liu G, Li J, Wu L, Tan Y, Zheng X, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant. 2012;27(5):1931‑7. 15. Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pellé T, Gaspari F, et al. AntiPhospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy. J Am Soc Nephrol. 2015;26(10):2545‑58. 16. Bech AP, Hofstra JM, Brenchley PE, Wetzels JFM. Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2014;9(8):1386‑92. 17. Hofstra JM, Beck LH, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286‑91. 18. Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RAK. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014;25(6):1357‑66. 19. Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RAK. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and nonnephrotic range proteinuria under treatment with inhibitors of the reninangiotensin system. PloS One. 2014;9 (10):e110681. 20. Kanigicherla D, Gummadova J, McKenzie EA, Roberts SA, Harris S, Nikam M, et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int. 2013;83 (5):940‑8. 21. Cambier J-F, Ronco P. Onco-nephrology: glomerular diseases with cancer. Clin J Am Soc Nephrol. 2012;7 (10):1701‑12.
Renvois
- Il n'y a présentement aucun renvoi.